Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes and Adverse Events Among Patients with Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL) Initiating First-Line (1L) Ibrutinib: Analysis of Subgroups Receiving Subsequent Second Generation (2G) Bruton Tyrosine Kinase Inhibitors, Non-Bruton Tyrosine Kinase Inhibitor Therapy, or Ibrutinib Retreatment in the US Community Oncology Setting

John M. Burke, Ira Zackon, Brittani Wayne, Yunfei Wang, John Murphy, Jennifer Prescott, Shravanthi Gandra, Siyang Leng, Enrico De Nigris

Blood (2024) 144 (Supplement 1): 7811.

https://doi.org/10.1182/blood-2024-203667

Published: 2024

Journal Articles

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

Michael Ellison, PhD, Natalie Briones, MS, Angelina Baroffio, John Murphy, Katherine Gowan, Bridget Sanford, Kenneth L. Jones, PhD, Daniel R. Ambruso, MD

Blood (2018) 132 (Supplement 1): 2398.

https://doi.org/10.1182/blood-2018-99-115314

Published: 2018

Journal Articles

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Stuart S. Winter, MD, Meenakshi Devidas, PhD, Brent Wood, MD, PhD, Michael J. Borowitz, MD, PhD, Mignon L. Loh, M.D., Barbara Asselin, MD, John Murphy, Elizabeth Raetz, MD, Naomi Winick, MD, Stephen Hunger, MD, William Carroll, MD, Kimberly Dunsmore, MD

Blood (2010) 116 (21): 865.

https://doi.org/10.1182/blood.V116.21.865.865

Published: 2010

Journal Articles

Involvement of the Tis11b/Berg36 Family in the Regulation of B-CLL Surivival and Differentiation.

Maria Baou, BSc, John Murphy, PhD, Kwee L. Yong, PhD, Robert Carr, MD, Andrew P. Jewell, PhD

Blood (2006) 108 (11): 4936.

https://doi.org/10.1182/blood.V108.11.4936.4936

Published: 2006

Journal Articles

Mode of Action of Rituximab in Chronic Lymphocytic Leukaemia; Activation of Tis11b, an Inducer of mRNA Instability, and Induction of Apoptosis.

Maria Baou, BSc, John Murphy, PhD, Andrew P. Jewell, PhD

Blood (2005) 106 (11): 2095.

https://doi.org/10.1182/blood.V106.11.2095.2095

Published: 2005

Journal Articles

Regulation of Berg-36 Gene Expression by Survival and Apoptotic Stimuli in B-Chronic Lymphocytic Leukaemia Cells.

Andrew P. Jewell, PhD, Maria Baou, BSc, Kwee L. Yong, PhD, Robert Carr, MD, John Murphy, PhD

Blood (2004) 104 (11): 4767.

https://doi.org/10.1182/blood.V104.11.4767.4767

Published: 2004

NARROW

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Involvement of the Tis11b/Berg36 Family in the Regulation of B-CLL Surivival and Differentiation.

Mode of Action of Rituximab in Chronic Lymphocytic Leukaemia; Activation of Tis11b, an Inducer of mRNA Instability, and Induction of Apoptosis.

Regulation of Berg-36 Gene Expression by Survival and Apoptotic Stimuli in B-Chronic Lymphocytic Leukaemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Involvement of the Tis11b/Berg36 Family in the Regulation of B-CLL Surivival and Differentiation.

Mode of Action of Rituximab in Chronic Lymphocytic Leukaemia; Activation of Tis11b, an Inducer of mRNA Instability, and Induction of Apoptosis.

Regulation of Berg-36 Gene Expression by Survival and Apoptotic Stimuli in B-Chronic Lymphocytic Leukaemia Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only